TY - JOUR
T1 - Association of IRS1 genetic variants with glucose control and insulin resistance in type 2 diabetic patients from Bosnia and Herzegovina
AU - Mahmutovic, Lejla
AU - Bego, Tamer
AU - Sterner, Maria
AU - Gremsperger, Gabriella
AU - Ahlqvist, Emma
AU - Velija Asimi, Zelija
AU - Prnjavorac, Besim
AU - Hamad, Nour
AU - Causevic, Adlija
AU - Groop, Leif
AU - Semiz, Sabina
PY - 2019
Y1 - 2019
N2 -
Previous studies reported conflicting results regarding association of insulin receptor substrate 1 (IRS1) gene variation with type 2 diabetes (T2D) and insulin resistance (IR) in different ethnic groups. We examined the association of rs7578326, rs2943641, and rs4675095 in the IRS1 gene with T2D and related traits in a population from Bosnia and Herzegovina, which is one of the European countries with the highest T2D prevalence of 12.5%. Our study included 390 T2D patients and 252 control subjects. Biochemical parameters, including fasting glucose (FG), fasting insulin (FI), homeostasis model assessment insulin resistance index (HOMA-IR), and HbA
1c
were measured in all participants. Genotyping analysis was performed by Mass Array Sequenom iPlex platform. Our results demonstrated that rs7578326 and rs4675095 variants were associated with increased FG levels. The rs7578326 was also associated with higher FI, HOMA-IR (B = 0.08, 95% CI [0.01, 0.15], p
add
= 0.025; B = 0.079, 95% CI [0.006, 0.150], p
add
= 0.033, respectively) in T2D, and with HbA
1c
(B = 0.034, 95% CI [0.003, 0.065], p
dom
= 0.035) in non-drug-treated T2D. In contrast, rs2943641 C allele was associated with lower FG levels in control subjects (B = -0.17, 95% CI [-0.03, -0.002], p
add
= 0.030) and HbA
1c
(B = 0.03, 95% CI [0.002, 0.06], p
dom
= 0.040) in non-drug-treated T2D. We report the association between common variants in IRS1 gene with insulin resistance, glucose, and HbA
1c
levels in Bosnia and Herzegovina's population.
AB -
Previous studies reported conflicting results regarding association of insulin receptor substrate 1 (IRS1) gene variation with type 2 diabetes (T2D) and insulin resistance (IR) in different ethnic groups. We examined the association of rs7578326, rs2943641, and rs4675095 in the IRS1 gene with T2D and related traits in a population from Bosnia and Herzegovina, which is one of the European countries with the highest T2D prevalence of 12.5%. Our study included 390 T2D patients and 252 control subjects. Biochemical parameters, including fasting glucose (FG), fasting insulin (FI), homeostasis model assessment insulin resistance index (HOMA-IR), and HbA
1c
were measured in all participants. Genotyping analysis was performed by Mass Array Sequenom iPlex platform. Our results demonstrated that rs7578326 and rs4675095 variants were associated with increased FG levels. The rs7578326 was also associated with higher FI, HOMA-IR (B = 0.08, 95% CI [0.01, 0.15], p
add
= 0.025; B = 0.079, 95% CI [0.006, 0.150], p
add
= 0.033, respectively) in T2D, and with HbA
1c
(B = 0.034, 95% CI [0.003, 0.065], p
dom
= 0.035) in non-drug-treated T2D. In contrast, rs2943641 C allele was associated with lower FG levels in control subjects (B = -0.17, 95% CI [-0.03, -0.002], p
add
= 0.030) and HbA
1c
(B = 0.03, 95% CI [0.002, 0.06], p
dom
= 0.040) in non-drug-treated T2D. We report the association between common variants in IRS1 gene with insulin resistance, glucose, and HbA
1c
levels in Bosnia and Herzegovina's population.
KW - fasting glucose
KW - HbA
KW - HOMA-IR
KW - insulin resistance
KW - IRS1
KW - single nucleotide polymorphism
U2 - 10.1515/dmpt-2018-0031
DO - 10.1515/dmpt-2018-0031
M3 - Article
C2 - 30888963
AN - SCOPUS:85063496696
SN - 2363-8907
VL - 34
JO - Drug Metabolism and Personalized Therapy
JF - Drug Metabolism and Personalized Therapy
IS - 1
M1 - 20180031
ER -